Prosecution Insights
Prosecution Insights
5 pending office actions • 3 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (60%) |
| §112 only | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEGESSE, NINI F | 1 | 68.5% | +14.6% |
| WILLIS, DOUGLAS M | 1 | 82.6% | +19.7% |
| MCCORMICK, CATHERINE LYNN | 1 | 46.9% | +21.8% |
| TRAN, SUSAN T | 1 | 62.8% | +36.0% |
| LEE, WILLIAM Y | 1 | 47.8% | +34.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261896 | PROCESS FOR MAKING IBRUTINIB | WILLIS, DOUGLAS M | 16d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17765934 | PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDE | LEE, WILLIAM Y | 147d overdue |
| 18555148 | GOLF PUTTING TRAINING DEVICE | LEGESSE, NINI F | 50d overdue |
| 18043176 | PHARMACEUTICAL COMPOSITION COMPRISING IBRUTINIB | TRAN, SUSAN T | 17d overdue |
| 18261896 | PROCESS FOR MAKING IBRUTINIB | WILLIS, DOUGLAS M | 16d |
| 18250873 | TISSUE SCAFFOLDS | MCCORMICK, CATHERINE LYNN | 27d |
| Client (Assignee) | Pending OAs |
|---|---|
| Synthon B.V. | 3 |
| Birdie Majik LLC | 1 |
| JD BIOMEDICAL SOLUTIONS LTD. | 1 |
| Art Unit | Apps |
|---|---|
| 3711 | 1 |
| 1624 | 1 |
| 1638 | 1 |
| 1615 | 1 |
| 1623 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18555148 | GOLF PUTTING TRAINING DEVICE | Birdie Majik LLC | LEGESSE, NINI F | 3711 | §103 | Non-Final OA | 50d overdue | Pending | Oct 12, 2023 |
| 18261896 | PROCESS FOR MAKING IBRUTINIB | Synthon B.V. | WILLIS, DOUGLAS M | 1624 | §112 | Non-Final OA | 16d | Pending | Jul 18, 2023 |
| 18250873 | TISSUE SCAFFOLDS | Jd Biomedical Solutions Ltd. | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Non-Final OA | 27d | Pending | Apr 27, 2023 |
| 18043176 | PHARMACEUTICAL COMPOSITION COMPRISING IBRUTINIB | Synthon B.V. | TRAN, SUSAN T | 1615 | §103 | Final Rejection | 17d overdue | Pending | Feb 27, 2023 |
| 17765934 | PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDE | Synthon B.V. | LEE, WILLIAM Y | 1623 | Other | Non-Final OA | 147d overdue | Pending | Apr 01, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial